Categories: News

Bybit Launches Enhanced VIP Exclusive Airdrop with Expanded Rewards and Flexible Prize Structure

DUBAI, UAE, Dec. 24, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is pleased to announce a comprehensive upgrade to its weekly VIP Exclusive Airdrop, introducing a more dynamic rewards system to accommodate diverse trading strategies and activity levels of Bybit’s trading pros.

- Advertisement -

Bybit VIP Privilege: More Prizes, More Choices

- Advertisement -

The upgraded program features 26 prizes distributed across three prize pools, each featuring different token types to align with personal preferences. Eligible participants can now choose from stablecoins, trending tokens, and platform featured tokens, accessing unprecedented flexibility in rewards.

- Advertisement -

The expanded VIP airdrop benefit reaffirms Bybit’s commitment to rewarding its exclusive community. In the high-octane arena of crypto trading, Bybit continues to refine and elevate the VIP experience and build a dependable, supportive platform.

- Advertisement -

Tiered Prize Pools

- Advertisement -

The new structure also caters to different experience levels for all VIPs:

- Advertisement -
  • Starter Pool: Immediately accessible to all registered VIPs
  • Expert Pool: Unlocks at $25 million in cumulative trading volume
  • Master Pool: Unlocks at $125 million in trading volume, featuring a top prize of $11,888

Lucky draw chances earned throughout the event can be utilized across any unlocked pool, giving VIP traders strategic control over their participation.

- Advertisement -

How it Works

- Advertisement -

From now until January 4, 2026, at 11:59 PM UTC, Bybit VIPs can receive complimentary and exclusive lucky draw chances based on their tier level, ranging from one chance for VIP1 members to six chances for Supreme VIP members. Additional chances can be earned by completing designated tasks during the event period.

- Advertisement -

Registration is required. Terms and conditions apply. For details on qualification rules and eligibility, users may visit: VIP Exclusive Airdrop: More prizes, more tokens, more choices!

- Advertisement -

#Bybit / #CryptoArk / #IMakeIt

- Advertisement -

About Bybit

- Advertisement -

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 80 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

- Advertisement -

For more details about Bybit, please visit Bybit Press

- Advertisement -

For media inquiries, please contact: media@bybit.com

- Advertisement -

For updates, please follow: Bybit’s Communities and Social Media

- Advertisement -

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

- Advertisement -

Photo – https://mma.prnewswire.com/media/2851521/Bybit_Launches_Enhanced_VIP_Exclusive_Airdrop_Expanded_Rewards_Flexible_Prize.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bybit-launches-enhanced-vip-exclusive-airdrop-with-expanded-rewards-and-flexible-prize-structure-302649213.html

- Advertisement -

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

2 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

2 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

2 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

2 hours ago